Skip to content

Ginkgo Bioworks DNA Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-210.7%-18.7pp-192%+7.5pp-199.5%-61.1pp-138.3%+65.2pp-203.5%+43.0pp
Net margin-215.4%-20.0pp-195.4%+3.7pp-199.1%-56.3pp-142.8%+64.9pp-207.7%+33.3pp
Returns
Return on equity-55.8%-4.7pp-51.1%-1.1pp-50%-6.4pp-43.6%+14.2pp-57.8%+2.6pp
Return on invested capital-42.8%+4.0pp-46.8%+1.6pp-48.3%+8.7pp-57%+30.2pp-87.2%+33.4pp
Efficiency
Asset turnover0.1×0.0×0.1×0.0×0.1×0.0×0.2×0.0×0.2×0.0×
Liquidity
Current ratio5.2×+0.2×4.9×+0.5×4.4×-1.0×5.4×+0.5×4.9×-0.7×
Leverage
Debt-to-equity0.9×+0.1×0.9×+0.1×0.8×+0.1×0.7×0.0×0.7×0.0×
Valuation
Market capitalization$625.16M+24.6%$503.5M-41.7%$863.13M+60.5%$537.91M+62.6%$330.79M-41.4%
Price / sales4.4×+2.2×3.1×-1.9×5.1×+2.6×2.4×+1.0×1.5×-1.0×
Price / book1.4×+0.6×-0.6×1.5×+0.7×0.9×+0.4×0.5×-0.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Ginkgo Bioworks's ratios come from?
Every ratio is computed from Ginkgo Bioworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.